Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 3,002 shares of common stock on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sanna, who has sold a total of 7,147 shares in the past three months, amounting to gross proceeds of $3,000,307.10. The notice of the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 08/25/2023.